Going forward, we estimate 25%, 24% and 19% Revenue, EBITDA and PAT CAGR respectively till FY24, driven by improvement in demand from exports and an increase in the utilization of the existing capacities. Further the increased focus on domestic business will help the company to scale its brand Carysil.